🇨🇦 HX575 recombinant human erythropoietin alfa in Canada

HX575 recombinant human erythropoietin alfa (HX575 recombinant human erythropoietin alfa) regulatory status in Canada.

Marketing authorisation

HX575 recombinant human erythropoietin alfa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is HX575 recombinant human erythropoietin alfa approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for HX575 recombinant human erythropoietin alfa in Canada?

Sandoz is the originator. The local marketing authorisation holder may differ — check the official source linked above.